Cargando…
Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion
Although drug-eluting stents (DES) have become the mainstay of percutaneous coronary intervention, late and very late stent thrombosis remains a concern. Drug-coated balloons (DCB) have the advantage of preserving the anti-restenotic benefits of DES while minimizing potential long-term safety concer...
Autores principales: | Shin, Eun-Seok, Bang, Liew Houng, Jun, Eun Jung, Her, Ae-Young, Chung, Ju-Hyun, Garg, Scot, Lee, Joo Myung, Doh, Joon-Hyung, Nam, Chang-Wook, Koo, Bon-Kwon, Tang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276995/ https://www.ncbi.nlm.nih.gov/pubmed/32789835 http://dx.doi.org/10.5603/CJ.a2020.0105 |
Ejemplares similares
-
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2016) -
Late lumen enlargement and plaque regression after drug-coated balloon treatment for an isolated ostial lesion of a diagonal branch
por: Yuan, Song Lin, et al.
Publicado: (2021) -
A case of a de-novo lesion in the left circumflex artery treated with excimer laser and drug-coated balloon under the guidance of optical frequency domain imaging
por: Masuda, Shinichiro, et al.
Publicado: (2019) -
Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of de novo Chronic Total Occlusions
por: Jun, Eun Jung, et al.
Publicado: (2022) -
Pushing the envelope: A drug-coated balloon for left main intervention
por: Uskela, Sanna, et al.
Publicado: (2022)